| Aug 28 |
Standard BioTools And 2 Other Penny Stocks Executives Are Buying
|
| Aug 13 |
CalciMedica GAAP EPS of -$0.36 beats by $0.22
|
| Aug 12 |
CalciMedica Reports Second Quarter 2024 Financial Results and Provides Clinical & Corporate Updates
|
| Jul 9 |
CalciMedica Announces First Patient Enrolled in Phase 2 KOURAGE Trial of Auxora™ in Severe Acute Kidney Injury (AKI)
|
| Jul 8 |
CalciMedica Announces Presentations at Two Upcoming Healthcare Investment Conferences
|
| Jun 26 |
CalciMedica to Host Conference Call to Review Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)
|
